|
November 28, 2006
|
Musculoskeletal Transplant Foundation & Affinergy Announce Strategic Alliance
EDISON, N.J., and RESEARCH TRIANGLE PARK, N.C., November 28, 2006 - The Musculoskeletal Transplant Foundation (MTF) and Affinergy announced today the formation of a multi-year strategic alliance to utilize Affinergy's peptide linkers to enhance a variety of MTF products. Affinergy will be working exclusively with MTF in the field of human allograft on a worldwide basis.
"MTF is continually seeking new technologies to enhance clinical outcomes for our patients while maintaining our primary focus on patient safety," said Bruce W. Stroever, President and CEO of MTF. "We envision a number of different MTF tissue forms where Affinergy's technology has the potential to help our patients recapture a meaningful quality of life. Our research team is fully committed to exploring the full potential of this strategic alliance and looks forward to a long-term partnership with Affinergy."
"MTF is the world's leading tissue bank, not just in size, but in quality systems as well as innovation," said Peyton Anderson, Affinergy's CEO. "Affinergy sees a great strategic fit between MTF's tissue forms and our technology to improve existing products and create new products. This strategic alliance further validates Affinergy's strategy of partnering on an exclusive basis with market leaders in their fields. Moreover, we are genuinely excited to help MTF in its ongoing mission to improve the quality of life for hundreds of thousands of patients each year."
About MTF
The Musculoskeletal Transplant Foundation is the world's largest tissue organization dedicated to providing quality tissue through a commitment to excellence in education, research, recovery and care for recipients, donors and their families. A not-for-profit organization, MTF is a consortium of academic medical institutions and organ and tissue recovery organizations across the country. In 2005, more than 340,000 tissue grafts were distributed by MTF, helping over 225,000 patients. The Musculoskeletal Transplant Foundation is a service organization dedicated to the advancement of bone, ligament, cartilage and skin transplantation. For more information, please visit MTF's website at www.mtf.org.
About Affinergy, Inc.
Affinergy develops site-specific biological systems using biofriendly linkers that selectively adhere to proteins, drugs, cells, and biomaterial surfaces in order to kickstart biology toward an intended outcome. Affinergy is focused on developing coatings and medical devices for the orthopedic and cardiovascular markets. Affinergy's technology was patented at Duke University and was awarded 2005 Innovation of the Year by Frost & Sullivan in the category of Medical Device Coatings. For more information, visit www.affinergy.com.
For more information:
Thomas Shaffer
Vice President, Marketing
Musculoskeletal Transplant Foundation
732-661-2522
Thomas_Shaffer@mtf.org
Peyton Anderson
Chief Executive Officer
Affinergy, Inc.
919-433-2229
panderson@affinergy.com
|
